Rising Pharmaceuticals, Inc. has recalled 15,072 bottles of Timolol Maleate sterile ophthalmic solution, a prescription eye medication used to treat glaucoma. The recall was issued because a case of the 0.25% strength medication was incorrectly packaged in outer cartons labeled as the 0.5% strength. While the bottle inside is the correct 0.25% strength, the discrepancy between the outer box and the inner bottle could lead to confusion regarding the dosage. These products were distributed nationwide across the United States.
A consumer might believe they are using a higher concentration of medication (0.5%) based on the outer box when they are actually using a lower concentration (0.25%). This labeling mix-up could result in patients receiving half of their intended dose if they rely on the outer carton for instructions, potentially leading to poorly controlled eye pressure.
Pharmaceutical product refund and consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.